Acute Congestive Glaucoma By . M. N. O. 4 th year medical Student( MBBCh )
Objective Overview mechanism Risk factors classification Symptoms and signs Management
overview PACG may be responsible for up to half of all cases of glaucoma globally, with a particularly high of Far Eastern descent . The term ‘angle closure’ refers to occlusion of the trabecular meshwork by the peripheral iris ( iridotrabecular contact – ITC), obstructing aqueous outflow
Relative Pupillary block Mechanism Relative pupillary block : Normally, aqueous humor is produced in the ciliary body, flows through the pupil into the anterior chamber, and drains into the trabecular meshwork to exit the eye. When the pupil is mid-dilated , the distance between the iris and the lens is the shortest, and the two structures can come into contact with each other in individuals at risk for angle closure. When this occurs, aqueous humor cannot flow through the pupil into the anterior chamber (pupillary block), pushing the iris forward. When the iris is pushed against the trabecular meshwork, aqueous humor cannot flow out of the eye (angle closure), increasing IOP.
Non-pupillary block Mechanism Non-pupillary block : Thought to be important in many Far Eastern patients. plateau iris younger than those with pure pupillary block. plateau; iris (anteriorly positioned/rotated ciliary processes , and a thicker or more anteriorly positioned iris a ‘thick peripheral iris roll’ iris-induced mechanisms
Risk factors Narrow angle (shallow anterior chamber) Age . The average age of relative pupillary block is about 60 years at presentation . Non-pupillary block forms of primary angle closure tend to occur at a younger age. • Gender . Females are more commonly affected than males. • Race . Particularly prevalent in Far Eastern and Indian Asians; in the former non-pupillary block is relatively more significant. • Refraction . pupillary block are typically hypermetropic , although one in six patients with hypermetropia more are primary angle closure suspects. • Axial length . Short eyes tend to have a shallow AC ; Pupillary dilatation : Mydriatic ,Excitement, dark place
Intermittent( prodromal ) stage Transient mild attack of Headache . blurred vision & halos around light The attack Is relived by sleep & exposure to light (due to miosis → lead to open angle)
Diagnosis History ( Recuttent attacks of headache & blurred Vission ) Gonioscopy : Narrow angle Tonometry Normal btw attacks ↑ durring attack Provocative tests : darkroom test Dark room/prone provocative test (DRPPT ) Mydriatic test ; positive if IOP rises > 8mmHg
symptoms ocular/ periocular pain and headache ; blurring (‘smoke-filled room’) & Colored haloes ☼ (‘rainbow around lights’) due to corneal epithelial edema Markedly ↓Decreased vision early , late Redness nausea and vomiting abdominal pain and other gastrointestinal symptoms may occur.
Medical Emergency
`
Signs Conjunctiva→ : Red eye ( ciliary injection ) circumcorneal injection. Cornea→ : cloudy/ edema Anterior chamber→ : shallow Iris→ : Iris bombe Pupil→ : semi-dilated, non-reactive ,oval vertical IOP→ : is usually very high ( 50–100 mmHg ). STONY HARD VA→: ↓ Sequelae of ischemia→: segmental iris atrophy (focal iris stroma necrosis ) dilated irregular pupil (sphincter and dilator necrosis) glaukomflecken (focal anterior lens opacities due to epithelial necrosis )
Treatment Hospitalization : patient should assume a supine position to encourage the lens to shift posteriorly under the influence of gravity. Systemic Treatment : IV Acetazolamide (( Diamox)) [ C/I sulfonamide allergy] IV mannitol [Circulatory overload C/I in heart failure] Topical Treatment M 3 agonist ( Pilocarpine ) → Miosis → (↓IOP) β-blocker ( Timolol ) → ↓AH syn. → (↓IOP) α2-agonist( Apraclonidine ) → ↓A.H. syn. → (↓IOP) Topical steroids for inflammation Analgesia and an Antiemetic may be required peripheral Iridotomy or iridectomy Prophylactic iridotomy or iridoectomy to other eye
References : Kanski’s Clinical Ophthalmology A SYSTEMATIC APPROACH 8 th ed. Review of Ophthalmology, 2nd Ed 2012 https :// emedicine.medscape.com https://www.webmd.com/